Response to the letter by Prof Jonathan Deeks to the Lancet EClinicalMedicine editor
Autores principales: | Leber, W, Lammel, O, Panovska-Griffiths, J, Czypionka, T |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Ejemplares similares
-
Corrigendum to ‘Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.’ [EClinicalMedicine 59 (2023) 101981]
por: Yuming Sun, et al.
Publicado: (2023-08-01) -
Corrigendum to “Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care” [EClinicalMedicine 28 (2020) 100,578]
por: Paolo Fusar-Poli, et al.
Publicado: (2021-02-01) -
Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
por: Vinicius Fontanesi Blum, MD, MSc, et al.
Publicado: (2021-11-01) -
Addendum to ‘A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis’ [EClinicalMedicine 24 (2020) 100442]
por: Candice Luo, et al.
Publicado: (2020-10-01) -
Corrigendum to “Sex differences in HIV treatment outcomes and adherence by exposure groups among adults in Guangdong, China: A retrospective observational cohort study” [EClinicalMedicine 22 (2020) 100351]
por: Linghua Li, et al.
Publicado: (2020-12-01)